This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamamoto, H. Articles by Moskal, J. R. Search for Related Content PubMed PubMed Citation Articles by Yamamoto, H. Articles by Moskal, J. R.

2,6-Sialylation of Cell-Surface N-Glycans Inhibits Glioma Formation in Vivo¹

Chicago Institute for Neurosurgery and Neuroresearch, Chicago, Illinois 60614

Human gliomas express very high levels of cell-surface 2,3-linked terminal sialic acids on glycoproteins bearing N-linked oligosaccharides, most notably on 3ß1 integrin, which is the predominant integrin found in these tumors. 2,6-linked terminal sialic acids, however, are not expressed. Two stable transfectants were made using a tumorigenic human glioma cell line, U-373 MG. Galß1,4GlcNAc 2,6-sialyltransferase (ST6Gal I) transfectants were made to replace the endogenous 2,3-linked sialic acids with 2,6-linked sialic acids. And Galß1,3(4)GlcNAc 2,3-sialyltransferase (ST3Gal III) transfectants were made to increase further the expression of cell-surface, N-glycan, 2,3-linked sialic acids. Although ST3Gal III transfection resulted in increased invasivity when compared with parental U-373 MG and vector-transfected control cells in vitro, ST6Gal I transfection abolished invasion in vitro and induced alterations in both cell morphology, cell-spreading, and adhesion-mediated protein tyrosine phosphorylation. Furthermore, the ST6Gal I transfectants produced no intracranial tumors in severe combined immunodeficient mice, whereas parental U-373 MG cells, the vector-transfected control cells, and ST3Gal III-transfected U-373 MG cells did. These results suggest that both the linkage and expression levels of the terminal sialic acids of 3ß1 integrin N-glycans play an important role in glioma cell-extracellular matrix interactions. Thus, manipulating ST6Gal I gene expression may have therapeutic potential for the treatment of malignant gliomas.

This article has been cited by other articles:

				M. Lee, H.-J. Lee, S. Bae, and Y.-S. Lee Protein Sialylation by Sialyltransferase Involves Radiation Resistance Mol. Cancer Res., August 1, 2008; 6(8): 1316 - 1325. [Abstract] [Full Text] [PDF]

				W. Li, K. Ishihara, T. Yokota, T. Nakagawa, N. Koyama, J. Jin, Y. Mizuno-Horikawa, X. Wang, E. Miyoshi, N. Taniguchi, et al. Reduced {alpha}4 1 Integrin/VCAM-1 Interactions Lead to Impaired Pre-B Cell Repopulation in Alpha 1,6-Fucosyltransferase Deficient Mice Glycobiology, January 1, 2008; 18(1): 114 - 124. [Abstract] [Full Text] [PDF]

				Y. Zhao, S. Itoh, X. Wang, T. Isaji, E. Miyoshi, Y. Kariya, K. Miyazaki, N. Kawasaki, N. Taniguchi, and J. Gu Deletion of Core Fucosylation on {alpha}3beta1 Integrin Down-regulates Its Functions J. Biol. Chem., December 15, 2006; 281(50): 38343 - 38350. [Abstract] [Full Text] [PDF]

				Y. Zhao, T. Nakagawa, S. Itoh, K.-i. Inamori, T. Isaji, Y. Kariya, A. Kondo, E. Miyoshi, K. Miyazaki, N. Kawasaki, et al. N-Acetylglucosaminyltransferase III Antagonizes the Effect of N-Acetylglucosaminyltransferase V on {alpha}3beta1 Integrin-mediated Cell Migration J. Biol. Chem., October 27, 2006; 281(43): 32122 - 32130. [Abstract] [Full Text] [PDF]

				M. Chiricolo, N. Malagolini, S. Bonfiglioli, and F. Dall'Olio Phenotypic changes induced by expression of {beta}-galactoside {alpha}2,6 sialyltransferase I in the human colon cancer cell line SW948 Glycobiology, February 1, 2006; 16(2): 146 - 154. [Abstract] [Full Text] [PDF]